{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:44:56Z","timestamp":1783187096642,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00270-019-02366-8","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T21:03:05Z","timestamp":1572901385000},"page":"254-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization"],"prefix":"10.1007","volume":"43","author":[{"given":"Alexa O.","family":"Levey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Ermentrout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini R.","family":"Kudchadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary L.","family":"Bercu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda L.","family":"Yushak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4569-2720","authenticated-orcid":false,"given":"Nima","family":"Kokabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"issue":"7","key":"2366_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11912-017-0606-5","volume":"19","author":"KM Komatsubara","year":"2017","unstructured":"Komatsubara KM, Carvajal RD. Immunotherapy for the treatment of uveal melanoma: current status and emerging therapies. Curr Oncol Rep. 2017;19(7):45.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"2366_CR2","doi-asserted-by":"crossref","first-page":"204798161557041","DOI":"10.1177\/2047981615570417","volume":"4","author":"J Schelhorn","year":"2015","unstructured":"Schelhorn J, Richly H, Ruhlmann M, Lauenstein TC, Theysohn JM. A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma. Acta Radiol Open. 2015;4(4):2047981615570417.","journal-title":"Acta Radiol Open"},{"issue":"2","key":"2366_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2214\/AJR.10.4881","volume":"196","author":"CF Gonsalves","year":"2011","unstructured":"Gonsalves CF, Eschelman DJ, Sullivan KL, Anne PR, Doyle L, Sato T. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. AJR Am J Roentgenol. 2011;196(2):468\u201373.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2366_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00270-012-0373-5","volume":"36","author":"A Klingenstein","year":"2013","unstructured":"Klingenstein A, Haug AR, Zech CJ, Schaller UC. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients. Cardiovasc Interv Radiol. 2013;36(1):158\u201365.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"15","key":"2366_CR5","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","volume":"122","author":"C Chattopadhyay","year":"2016","unstructured":"Chattopadhyay C, Kim DW, Gombos DS, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016;122(15):2299\u2013312.","journal-title":"Cancer"},{"issue":"5","key":"2366_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11912-013-0337-1","volume":"15","author":"DB Page","year":"2013","unstructured":"Page DB, Postow MA, Callahan MK, Wolchok JD. Checkpoint modulation in melanoma: an update on ipilimumab and future directions. Curr Oncol Rep. 2013;15(5):500\u20138.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"2366_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/COC.0b013e3181b4b065","volume":"33","author":"S Gupta","year":"2010","unstructured":"Gupta S, Bedikian AY, Ahrar J, et al. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol. 2010;33(5):474\u201380.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"2366_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.seminoncol.2010.03.014","volume":"37","author":"T Sato","year":"2010","unstructured":"Sato T. Locoregional management of hepatic metastasis from primary uveal melanoma. Semin Oncol. 2010;37(2):127\u201338.","journal-title":"Semin Oncol"},{"issue":"1","key":"2366_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/COC.0000000000000109","volume":"40","author":"M Xing","year":"2017","unstructured":"Xing M, Prajapati HJ, Dhanasekaran R, et al. Selective internal yttrium-90 radioembolization therapy (90Y-SIRT) versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to systemic therapy: safety and efficacy cohort study. Am J Clin Oncol. 2017;40(1):27\u201334.","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"2366_CR10","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jvir.2018.04.030","volume":"29","author":"J Zheng","year":"2018","unstructured":"Zheng J, Irani Z, Lawrence D, Flaherty K, Arellano RS. Combined effects of yttrium-90 transarterial radioembolization around immunotherapy for hepatic metastases from uveal melanoma: a preliminary retrospective case series. J Vasc Interv Radiol. 2018;29(10):1369\u201375.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"2366_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jvir.2014.11.037","volume":"26","author":"ME Valsecchi","year":"2015","unstructured":"Valsecchi ME, Terai M, Eschelman DJ, et al. Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases. J Vasc Interv Radiol. 2015;26(4):523\u201332.","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"2366_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaophthalmol.2018.2466","volume":"136","author":"AM Lane","year":"2018","unstructured":"Lane AM, Kim IK, Gragoudas ES. Survival rates in patients after treatment for metastasis from uveal melanoma. JAMA Ophthalmol. 2018;136(9):981\u20136.","journal-title":"JAMA Ophthalmol"},{"key":"2366_CR13","unstructured":"Gil-Alzugaray et al. (2017). SIR-spheres Y-90 resin microspheres (yttrium-90 microspheres). Retrieved from \nhttps:\/\/www.sirtex.com\/media\/155126\/ssl-us-13.pdf\n\n. Accessed 1 Mar 2019."},{"issue":"7","key":"2366_CR14","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","volume":"17","author":"MB Atkins","year":"1999","unstructured":"Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999;17(7):2105\u201316.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2366_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/COC.0b013e3181f47923","volume":"35","author":"D Coldwell","year":"2012","unstructured":"Coldwell D, Sangro B, Salem R, Wasan H, Kennedy A. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers. Am J Clin Oncol. 2012;35(2):167\u201377.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"2366_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/MEG.0000000000000772","volume":"29","author":"MN Braat","year":"2017","unstructured":"Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG. Radioembolization-induced liver disease: a systematic review. Eur J Gastroenterol Hepatol. 2017;29(2):144\u201352.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"2366_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1084\/jem.20052494","volume":"203","author":"EA Reits","year":"2006","unstructured":"Reits EA, Hodge JW, Herberts CA, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med. 2006;203(5):1259\u201371.","journal-title":"J Exp Med"},{"issue":"2","key":"2366_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.18632\/oncotarget.1719","volume":"5","author":"SR Gameiro","year":"2014","unstructured":"Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget. 2014;5(2):403\u201316.","journal-title":"Oncotarget"},{"issue":"2","key":"2366_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","volume":"124","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Burnette B, et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Investig. 2014;124(2):687\u201395.","journal-title":"J Clin Investig"},{"issue":"17","key":"2366_CR20","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","volume":"15","author":"MZ Dewan","year":"2009","unstructured":"Dewan MZ, Galloway AE, Kawashima N, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res. 2009;15(17):5379\u201388.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2366_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/CMR.0000000000000343","volume":"27","author":"M Itchins","year":"2017","unstructured":"Itchins M, Ascierto PA, Menzies AM, et al. A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy. Melanoma Res. 2017;27(3):243\u201350.","journal-title":"Melanoma Res"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-019-02366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-019-02366-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-019-02366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:10:18Z","timestamp":1604362218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-019-02366-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1007\/s00270-019-02366-8","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. For this study, no formal consent is required. The study was approved by IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"This study has obtained IRB approval (indicate the relevant board) and the need for informed consent was waived. For this type of study, consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}